IP Library Granted Patent US 7,489,969
Granted Patent B2
US 7,489,969 · App. 10/674,330 · Granted Feb 10, 2009

Vagal down-regulation obesity treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,489,969
App. No.
10/674,330
Granted
Feb 10, 2009
Kind
B2
Abstract

Obesity is treated by applying a non-ablative, non-systemic therapy to a vagus nerve of an obese patient at a site below a vagal innervation of a heart. The therapy is selected to at least partially down-regulate a neural activity on the vagus nerve of the obese patient. The therapy is applied in a manner to down-regulate at least afferent signals on the vagus nerve.

Claims (12)

1. A method for treating obesity of an obese patient by applying a neural treatment comprising:

applying an electrode to a vagus nerve of the obese patient at a site below a vagal innervation of a heart of the patient to deliver an electrical signal and with the electrical signal applied by a device with a component chronically implanted within the patient's body; and

applying the electrical signal to the vagus nerve intermittently multiple times in a day and over multiple days, wherein the electrical signal is selected to a) at least partially block at least an afferent neural activity on the vagus nerve without ablating the vagus nerve of the obese patient; b) allow at least partial restoration of nerve activity following discontinuation of application of the signal to the nerve; and c) reduce pancreo-biliary output; wherein the electrical signal is not applied in response to a sensed event.

2. A method according to claim 1 wherein said neural treatment is regulated to heighten a sensation of satiety of said patient.

3. A method according to claim 1 wherein the electrode is applied at a vagal trunk.

4. A method according to claim 1 wherein the electrode is applied at a vagal branch.

5. A method according to claim 1 wherein the electrode is applied at both anterior and posterior vagus nerves of the patient.

6. A method according to claim 1 wherein the electrode is applied at the vagus nerve at a location near or distal to a diaphragm of the patient.

7. A method according to claim 1 wherein the neural treatment is further selected to at least partially block efferent nerve signals.

8. A method for treating obesity in a patient comprising:

applying a treatment comprising a reversible intermittent electrical signal by placing an electrode on a vagus nerve of the patient at a site below a vagal innervation of a heart of the patient by a device with a component chronically implanted within the patient's body;

wherein the electrical signal is selected to a) at least partially block at least an afferent neural activity on the vagus nerve of the patient; b) allow at least partial restoration of nerve activity following discontinuation of application of the signal to the nerve; and c) reduce pancreo-biliary output; wherein the electrical signal is not applied in response to a sensed event.

Assignments (2)
SECURITY INTEREST Recorded Jun 19, 2020
From: RESHAPE LIFESCIENCES INC.; RESHAPE MEDICAL LLC
To: ARMISTICE CAPITAL MASTER FUND LTD.
Reel/Frame 052987/0463 →
CHANGE OF NAME Recorded Mar 30, 2018
From: ENTEROMEDICS INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 045949/0495 →